Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease

Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits

Soho House Revenue Falls Short Despite 21% Membership Growth

Novo to Build $6 Billion Plant as Obesity Drug Demand Surges

Asia Markets Under Pressure After Treasuries Slip : Markets Wrap

Buffett’s Cash at Record $157 Billion After Deal Slump

The First Commercial Carbon-Sucking Facility in the US Opens in California

Astra Enters Obesity Drug Race With Chinese Biotech Deal

China Healthcare Stocks On Recovery Path After $142 Billion Rout

Japanese Funds Buy Most US Debt in Half Year, Pressuring Yen

Asian Stocks to Climb as S&P 500 Hits Hot Streak: Markets Wrap

New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper